Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

A proteome-wide immuno-mass spectrometric identification of serum autoantibodies.

Music M, Soosaipillai A, Batruch I, Prassas I, Bogdanos DP, Diamandis EP.

Clin Proteomics. 2019 Jun 20;16:25. doi: 10.1186/s12014-019-9246-0. eCollection 2019.

2.

Urine Angiotensin II Signature Proteins as Markers of Fibrosis in Kidney Transplant Recipients.

Mohammed-Ali Z, Tokar T, Batruch I, Reid S, Tavares-Brum A, Yip P, Cardinal H, Hébert MJ, Li Y, Kim SJ, Jurisica I, John R, Konvalinka A.

Transplantation. 2019 Jun;103(6):e146-e158. doi: 10.1097/TP.0000000000002676.

PMID:
30801542
3.

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progression.

Begcevic I, Tsolaki M, Brinc D, Brown M, Martinez-Morillo E, Lazarou I, Kozori M, Tagaraki F, Nenopoulou S, Gkioka M, Lazarou E, Lim B, Batruch I, Diamandis EP.

F1000Res. 2018 Jul 5;7:1012. doi: 10.12688/f1000research.15095.1. eCollection 2018.

4.

Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics.

Leung F, Bernardini MQ, Liang K, Batruch I, Rouzbahman M, Diamandis EP, Kulasingam V.

Version 2. F1000Res. 2018 Feb 14 [revised 2018 Jan 1];7:189. doi: 10.12688/f1000research.13863.2. eCollection 2018.

5.

Targeted Mass Spectrometry-Based Assays for Relative Quantification of 30 Brain-Related Proteins and Their Clinical Applications.

Begcevic I, Brinc D, Dukic L, Simundic AM, Zavoreo I, Basic Kes V, Martinez-Morillo E, Batruch I, Drabovich AP, Diamandis EP.

J Proteome Res. 2018 Jul 6;17(7):2282-2292. doi: 10.1021/acs.jproteome.7b00768. Epub 2018 Jun 6.

PMID:
29708756
6.

Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach.

Begcevic I, Brinc D, Brown M, Martinez-Morillo E, Goldhardt O, Grimmer T, Magdolen V, Batruch I, Diamandis EP.

J Proteomics. 2018 Jun 30;182:12-20. doi: 10.1016/j.jprot.2018.04.027. Epub 2018 Apr 22.

PMID:
29684683
7.

Spatiotemporal Proteomic Profiling of Human Cerebral Development.

Djuric U, Rodrigues DC, Batruch I, Ellis J, Shannon P, Diamandis P.

Mol Cell Proteomics. 2017 Sep;16(9):1548-1562. doi: 10.1074/mcp.M116.066274. Epub 2017 Jul 7.

8.

Stable Isotope Labeling with Amino Acids (SILAC)-Based Proteomics of Primary Human Kidney Cells Reveals a Novel Link between Male Sex Hormones and Impaired Energy Metabolism in Diabetic Kidney Disease.

Clotet S, Soler MJ, Riera M, Pascual J, Fang F, Zhou J, Batruch I, Vasiliou SK, Dimitromanolakis A, Barrios C, Diamandis EP, Scholey JW, Konvalinka A.

Mol Cell Proteomics. 2017 Mar;16(3):368-385. doi: 10.1074/mcp.M116.061903. Epub 2017 Jan 4.

9.

Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring.

Konvalinka A, Batruch I, Tokar T, Dimitromanolakis A, Reid S, Song X, Pei Y, Drabovich AP, Diamandis EP, Jurisica I, Scholey JW.

Clin Proteomics. 2016 Aug 5;13:16. doi: 10.1186/s12014-016-9117-x. eCollection 2016.

10.

An integrated proteomic and peptidomic assessment of the normal human urinome.

Di Meo A, Batruch I, Yousef AG, Pasic MD, Diamandis EP, Yousef GM.

Clin Chem Lab Med. 2017 Feb 1;55(2):237-247. doi: 10.1515/cclm-2016-0390.

PMID:
27394047
11.

Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays.

Karakosta TD, Soosaipillai A, Diamandis EP, Batruch I, Drabovich AP.

Mol Cell Proteomics. 2016 Sep;15(9):2863-76. doi: 10.1074/mcp.M115.057695. Epub 2016 Jul 1.

12.

Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas.

Begcevic I, Brinc D, Drabovich AP, Batruch I, Diamandis EP.

Clin Proteomics. 2016 May 15;13:11. doi: 10.1186/s12014-016-9111-3. eCollection 2016.

13.

Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1).

Musrap N, Tuccitto A, Karagiannis GS, Saraon P, Batruch I, Diamandis EP.

J Biol Chem. 2015 Jul 10;290(28):17218-27. doi: 10.1074/jbc.M115.639773. Epub 2015 May 24.

14.

Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers.

Cretu D, Liang K, Saraon P, Batruch I, Diamandis EP, Chandran V.

Clin Proteomics. 2015 Jan 13;12(1):1. doi: 10.1186/1559-0275-12-1. eCollection 2015.

15.

Delineating monoclonal antibody specificity by mass spectrometry.

Korbakis D, Prassas I, Brinc D, Batruch I, Krastins B, Lopez MF, Diamandis EP.

J Proteomics. 2015 Jan 30;114:115-24. doi: 10.1016/j.jprot.2014.11.004. Epub 2014 Nov 15.

PMID:
25462431
16.

Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry.

Cretu D, Prassas I, Saraon P, Batruch I, Gandhi R, Diamandis EP, Chandran V.

Clin Proteomics. 2014 Jul 1;11(1):27. doi: 10.1186/1559-0275-11-27. eCollection 2014.

17.

Deciphering the peptidome of urine from ovarian cancer patients and healthy controls.

Smith CR, Batruch I, Bauça JM, Kosanam H, Ridley J, Bernardini MQ, Leung F, Diamandis EP, Kulasingam V.

Clin Proteomics. 2014 Jun 2;11(1):23. doi: 10.1186/1559-0275-11-23. eCollection 2014.

18.

Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction.

Musrap N, Karagiannis GS, Saraon P, Batruch I, Smith C, Diamandis EP.

J Proteomics. 2014 May 30;103:204-15. doi: 10.1016/j.jprot.2014.03.042. Epub 2014 Apr 12.

PMID:
24726482
19.

In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.

Karagiannis GS, Pavlou MP, Saraon P, Musrap N, Xie A, Batruch I, Prassas I, Dimitromanolakis A, Petraki C, Diamandis EP.

J Proteomics. 2014 May 30;103:121-36. doi: 10.1016/j.jprot.2014.03.018. Epub 2014 Mar 27.

PMID:
24681409
20.

Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms.

Martínez-Morillo E, Nielsen HM, Batruch I, Drabovich AP, Begcevic I, Lopez MF, Minthon L, Bu G, Mattsson N, Portelius E, Hansson O, Diamandis EP.

J Proteome Res. 2014 Feb 7;13(2):1077-87. doi: 10.1021/pr401060x. Epub 2014 Jan 14.

PMID:
24392642
21.

Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin.

Karagiannis GS, Schaeffer DF, Cho CK, Musrap N, Saraon P, Batruch I, Grin A, Mitrovic B, Kirsch R, Riddell RH, Diamandis EP.

Mol Oncol. 2014 Mar;8(2):178-95. doi: 10.1016/j.molonc.2013.10.008. Epub 2013 Nov 8.

22.

Differential diagnosis of azoospermia with proteomic biomarkers ECM1 and TEX101 quantified in seminal plasma.

Drabovich AP, Dimitromanolakis A, Saraon P, Soosaipillai A, Batruch I, Mullen B, Jarvi K, Diamandis EP.

Sci Transl Med. 2013 Nov 20;5(212):212ra160. doi: 10.1126/scitranslmed.3006260.

23.

Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis.

Yuen DA, Connelly KA, Zhang Y, Advani SL, Thai K, Kabir G, Kepecs D, Spring C, Smith C, Batruch I, Kosanam H, Advani A, Diamandis E, Marsden PA, Gilbert RE.

Stem Cells. 2013 Nov;31(11):2408-19. doi: 10.1002/stem.1502.

24.

Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.

Saraon P, Cretu D, Musrap N, Karagiannis GS, Batruch I, Drabovich AP, van der Kwast T, Mizokami A, Morrissey C, Jarvi K, Diamandis EP.

Mol Cell Proteomics. 2013 Jun;12(6):1589-601. doi: 10.1074/mcp.M112.023887. Epub 2013 Feb 26.

25.

Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids.

Kuzmanov U, Musrap N, Kosanam H, Smith CR, Batruch I, Dimitromanolakis A, Diamandis EP.

Clin Chem Lab Med. 2013 Jul;51(7):1467-76. doi: 10.1515/cclm-2012-0642.

PMID:
23241603
26.

Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.

Saraon P, Musrap N, Cretu D, Karagiannis GS, Batruch I, Smith C, Drabovich AP, Trudel D, van der Kwast T, Morrissey C, Jarvi KA, Diamandis EP.

J Biol Chem. 2012 Oct 5;287(41):34019-31. doi: 10.1074/jbc.M112.384438. Epub 2012 Aug 20.

27.

Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies.

Prakash A, Rezai T, Krastins B, Sarracino D, Athanas M, Russo P, Zhang H, Tian Y, Li Y, Kulasingam V, Drabovich A, Smith CR, Batruch I, Oran PE, Fredolini C, Luchini A, Liotta L, Petricoin E, Diamandis EP, Chan DW, Nelson R, Lopez MF.

J Proteome Res. 2012 Aug 3;11(8):3986-95. doi: 10.1021/pr300014s. Epub 2012 Jul 3.

28.

Separation of kallikrein 6 glycoprotein subpopulations in biological fluids by anion-exchange chromatography coupled to ELISA and identification by mass spectrometry.

Kuzmanov U, Smith CR, Batruch I, Soosaipillai A, Diamandis A, Diamandis EP.

Proteomics. 2012 Mar;12(6):799-809. doi: 10.1002/pmic.201100371.

PMID:
22539431
29.

Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry.

Kagedan D, Lecker I, Batruch I, Smith C, Kaploun I, Lo K, Grober E, Diamandis EP, Jarvi KA.

Clin Proteomics. 2012 Feb 6;9(1):2. doi: 10.1186/1559-0275-9-2.

30.

Differential proteomic analysis of bronchoalveolar lavage fluid from lung transplant patients with and without chronic graft dysfunction.

Kosanam H, Sato M, Batruch I, Smith C, Keshavjee S, Liu M, Diamandis EP.

Clin Biochem. 2012 Feb;45(3):223-30. doi: 10.1016/j.clinbiochem.2011.11.015. Epub 2011 Dec 14.

PMID:
22206736
31.

Analysis of seminal plasma from patients with non-obstructive azoospermia and identification of candidate biomarkers of male infertility.

Batruch I, Smith CR, Mullen BJ, Grober E, Lo KC, Diamandis EP, Jarvi KA.

J Proteome Res. 2012 Mar 2;11(3):1503-11. doi: 10.1021/pr200812p. Epub 2012 Feb 2.

PMID:
22188163
32.

Digitoxin-induced cytotoxicity in cancer cells is mediated through distinct kinase and interferon signaling networks.

Prassas I, Karagiannis GS, Batruch I, Dimitromanolakis A, Datti A, Diamandis EP.

Mol Cancer Ther. 2011 Nov;10(11):2083-93. doi: 10.1158/1535-7163.MCT-11-0421. Epub 2011 Aug 22.

33.

Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.

Makawita S, Smith C, Batruch I, Zheng Y, Rückert F, Grützmann R, Pilarsky C, Gallinger S, Diamandis EP.

Mol Cell Proteomics. 2011 Oct;10(10):M111.008599. doi: 10.1074/mcp.M111.008599. Epub 2011 Jun 7.

34.

Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay.

Cho CK, Drabovich AP, Batruch I, Diamandis EP.

J Proteomics. 2011 Sep 6;74(10):2052-9. doi: 10.1016/j.jprot.2011.05.025. Epub 2011 May 20.

PMID:
21624510
35.

Immuno-mass spectrometry: quantification of low-abundance proteins in biological fluids.

Kulasingam V, Smith CR, Batruch I, Diamandis EP.

Methods Mol Biol. 2011;728:207-18. doi: 10.1007/978-1-61779-068-3_13.

PMID:
21468950
36.

Proteomic analysis of seminal plasma from normal volunteers and post-vasectomy patients identifies over 2000 proteins and candidate biomarkers of the urogenital system.

Batruch I, Lecker I, Kagedan D, Smith CR, Mullen BJ, Grober E, Lo KC, Diamandis EP, Jarvi KA.

J Proteome Res. 2011 Mar 4;10(3):941-53. doi: 10.1021/pr100745u. Epub 2011 Feb 14.

PMID:
21142078
37.

Thermodynamic and NMR analysis of inhibitor binding to dihydrofolate reductase.

Batruch I, Javasky E, Brown ED, Organ MG, Johnson PE.

Bioorg Med Chem. 2010 Dec 15;18(24):8485-92. doi: 10.1016/j.bmc.2010.10.048. Epub 2010 Oct 26.

PMID:
21084197
38.

Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays.

Prakash A, Rezai T, Krastins B, Sarracino D, Athanas M, Russo P, Ross MM, Zhang H, Tian Y, Kulasingam V, Drabovich AP, Smith C, Batruch I, Liotta L, Petricoin E, Diamandis EP, Chan DW, Lopez MF.

J Proteome Res. 2010 Dec 3;9(12):6678-88. doi: 10.1021/pr100821m. Epub 2010 Nov 2.

PMID:
20945832
39.

Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid.

Oikonomopoulou K, Batruch I, Smith CR, Soosaipillai A, Diamandis EP, Hollenberg MD.

Biol Chem. 2010 Apr;391(4):381-90. doi: 10.1515/BC.2010.045.

PMID:
20180649
40.

Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.

Gunawardana CG, Kuk C, Smith CR, Batruch I, Soosaipillai A, Diamandis EP.

J Proteome Res. 2009 Oct;8(10):4705-13. doi: 10.1021/pr900411g.

PMID:
19663500
41.

Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers.

Kuk C, Kulasingam V, Gunawardana CG, Smith CR, Batruch I, Diamandis EP.

Mol Cell Proteomics. 2009 Apr;8(4):661-9. doi: 10.1074/mcp.M800313-MCP200. Epub 2008 Dec 1.

42.

"Product ion monitoring" assay for prostate-specific antigen in serum using a linear ion-trap.

Kulasingam V, Smith CR, Batruch I, Buckler A, Jeffery DA, Diamandis EP.

J Proteome Res. 2008 Feb;7(2):640-7. doi: 10.1021/pr7005999. Epub 2008 Jan 11.

PMID:
18186600
43.

A combined NMR and molecular dynamics study of the transmembrane solubility and diffusion rate profile of dioxygen in lipid bilayers.

Al-Abdul-Wahid MS, Yu CH, Batruch I, Evanics F, Pomès R, Prosser RS.

Biochemistry. 2006 Sep 5;45(35):10719-28.

PMID:
16939224

Supplemental Content

Loading ...
Support Center